Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Benzo Oxygen Containing Heterocyclic Compound And Medical Application Thereof
Abstract: Disclosed in the present invention are a compound represented by formula Ib or IIb, a cis or trans isomer, enantiomer, diastereomer, racemate, tautomer, solvate, hydrate, and pharmaceutically acceptable salt thereof, or a mixture thereof, a pharmaceutical composition containing the compound, and a use of the compound as a GPR40 agonist, wherein n, E, G1, L1, L2, R1, R2, R3, R4, R5, R5b, R6, R7, X5, X6, X7, Y, Y1, Z, Z1, and the possible isotope substitution label of each element in the compound are as defined in the description.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
07 April 2023
Publication Number
47/2023
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Applicants
AB PHARMA LTD.
133-99 Guang Zhong Road Minhang District
Shanghai 201108
Inventors
1. ZHAN, Zhengyun
133-99 Guang Zhong Road Minhang District
Shanghai 201108
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202317026263.pdf | 2023-04-07 |
| 2 | 202317026263-STATEMENT OF UNDERTAKING (FORM 3) [07-04-2023(online)].pdf | 2023-04-07 |
| 3 | 202317026263-PRIORITY DOCUMENTS [07-04-2023(online)].pdf | 2023-04-07 |
| 4 | 202317026263-FORM 1 [07-04-2023(online)].pdf | 2023-04-07 |
| 5 | 202317026263-DECLARATION OF INVENTORSHIP (FORM 5) [07-04-2023(online)].pdf | 2023-04-07 |
| 6 | 202317026263-COMPLETE SPECIFICATION [07-04-2023(online)].pdf | 2023-04-07 |
| 7 | 202317026263-Proof of Right [06-07-2023(online)].pdf | 2023-07-06 |
| 8 | 202317026263-FORM-26 [06-07-2023(online)].pdf | 2023-07-06 |
| 9 | 202317026263-FORM 3 [28-09-2023(online)].pdf | 2023-09-28 |
| 10 | 202317026263-FORM 18 [02-08-2024(online)].pdf | 2024-08-02 |